2014, Number 110
<< Back Next >>
Rev Enfer Infec Pediatr 2014; 27.28 (110)
Expert Opinion on Perinatal Infections (Part 2) HIV
Vázquez LN, Ortiz J, Domínguez C
Language: Spanish
References: 6
Page: 519-528
PDF size: 337.63 Kb.
Text Extraction
No abstract
REFERENCES
Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. . July 31, 2012. http://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf
British HIV Association guidelines for the management of HIV infection in pregnant women 2012. HIV Medicine 2012; 13 (Suppl. 2): 87–157.
Joao EC, Calvet GA, Krauss MR, Freimanis Hance L, Ortiz J, Ivalo SA, Pierre R, Reyes M, Heather Watts D, Read JS. Maternal Antiretroviral Use during Pregnancy and Infant Congenital Anomalies: The NISDI Perinatal Study. J Acquir Immune Defic Syndr. 2010 February 1; 53(2): 176–185.
Read S. J., Cahn P., Lasso M., Management of Human Immunodeficiency Virus-Infected Pregnant Women al Latin American and Caribbean Sites. Obstetrics & Ginecology 2007; 109 (6): 1358-1367.
Plazola Camacho N, Ortiz Ibarra FJ Veinte años de experiencia en el manejo de la mujer embarazada infectada por VIH/SIDA en el Instituto Nacional de Perinatología. Bol Med Hosp Infant Mex 2009; 66:350-366
D'Ippolito M, Read JS, Korelitz J, João EC, Mussi-Pinhata M, Rocha N; NISDI Perinatal Study Group. Missed opportunities for prevention of mother-to-child transmission of human immunodeficiency virus type 1. Latin America Pediatr Infect Dis J. 2007 Jul; 26 (7):649-53 and the Caribbean: the NISDI perinatal study.
Full text